FT

AstraZeneca’s $39bn Alexion deal marks shift from prey to predator

Photo of Financial Times Financial Times
0 Less than a minute

Purchase of US rare disease specialist comes 6 years after pharma group saw off Pfizer takeover bid

Photo of Financial Times Financial Times
0 Less than a minute
Photo of Financial Times

Financial Times

Related Articles

Austria announces strict lockdown as virus cases soar

Trump says he will not participate in virtual debate

South Korea’s IPO market set for best year since 2017

Biden stresses ‘urgent business’ as Senate takes up impeachment

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Back to top button